• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    ---
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMRPI
Mera Pharmaceuticals Inc
560.0
0.0x
---
United StatesQBIO
Q BioMed Inc
14.5K
0.0x
---
United StatesIMVIF
IMV Inc
10.0
0.0x
---
United StatesERGO
Entia Biosciences Inc
6.7K
0.0x
---
United StatesNTBLQ
Notable Labs Ltd
194.6K
0.0x
---
United StatesMNKA
Manuka Inc
235.3K
-0.2x
---
As of 2024-11-22

Company Information

Mera Pharmaceuticals, Inc. is a marine biotechnology company. The Company focuses on photobioreactor technology and owns intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The Company manufactures natural astaxanthin from Haematococcus pluvialis microalgae. Through its research and development, the Company has formulated AstaFactor, an astaxanthin supplement with antioxidant and anti-inflammatory activity, which is available in three formulations, such as rejuvenating formula, sports formula and salmon essentials, such as natural astaxanthin combined with a blend of fish and salmon oil. The Company also produces sea salt products, such as gourmet salt and nigari. The gourmet salt includes Hawaiian Furikake, Hawaiian Furikake refillable grinder, Kona Sea Salt, Kona Sea Salt flake salt case, Kona Sea Salt grinder and Kona Sea Salt grinder case. The Company offers nigari in sizes ranging from one gallon to 250 gallons.

Contact Information

Headquarters
73-4460 Queen Kaahumanu Hwy, Suite 110KAILUA-KONA, HI, United States 96740
Phone
954-648-2013
Fax
302-655-5049

Executives

President, Company Secretary, Interim Director
Benny Doro
Chief Financial Officer
Charles Spaniak
Treasurer, Director
Rafi Markarians
Secretary, Director
Joyce Markley

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$560.00
Revenue (TTM)
$302.6K
Shares Outstanding
557.3M
Mera Pharmaceuticals Inc does not pay a dividend.
Beta
---
EPS
$0.00
Book Value
$0.00
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-66.43%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.